Adams Street Partners’s Corvus Pharmaceuticals CRVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $48.9M | Hold |
3,275,616
| – | – | 11.06% | 4 |
|
|
2026
Q1 | $47.9M | Hold |
3,275,616
| – | – | 18.41% | 3 |
|
|
2025
Q4 | $25.2M | Hold |
3,275,616
| – | – | 9.56% | 3 |
|
|
2025
Q3 | $24.1M | Hold |
3,275,616
| – | – | 15.76% | 2 |
|
|
2025
Q2 | $13.1M | Hold |
3,275,616
| – | – | 9.23% | 3 |
|
|
2025
Q1 | $10.4M | Hold |
3,275,616
| – | – | 9.22% | 3 |
|
|
2024
Q4 | $17.5M | Hold |
3,275,616
| – | – | 15.53% | 2 |
|
|
2024
Q3 | $17.3M | Hold |
3,275,616
| – | – | 9.52% | 5 |
|
|
2024
Q2 | $5.96M | Hold |
3,275,616
| – | – | 2.46% | 6 |
|
|
2024
Q1 | $5.83M | Hold |
3,275,616
| – | – | 2.32% | 7 |
|
|
2023
Q4 | $5.77M | Hold |
3,275,616
| – | – | 1.78% | 9 |
|
|
2023
Q3 | $4.78M | Hold |
3,275,616
| – | – | 1.67% | 9 |
|
|
2023
Q2 | $7.5M | Hold |
3,275,616
| – | – | 1.96% | 10 |
|
|
2023
Q1 | $2.98M | Hold |
3,275,616
| – | – | 0.93% | 8 |
|
|
2022
Q4 | $2.78M | Hold |
3,275,616
| – | – | 0.93% | 9 |
|
|
2022
Q3 | $2.68M | Hold |
3,275,616
| – | – | 0.73% | 9 |
|
|
2022
Q2 | $3.24M | Hold |
3,275,616
| – | – | 0.84% | 9 |
|
|
2022
Q1 | $5.37M | Hold |
3,275,616
| – | – | 0.99% | 9 |
|
|
2021
Q4 | $7.89M | Hold |
3,275,616
| – | – | 1.2% | 10 |
|
|
2021
Q3 | $15.9M | Hold |
3,275,616
| – | – | 2.03% | 9 |
|
|
2021
Q2 | $8.75M | Hold |
3,275,616
| – | – | 1.82% | 8 |
|
|
2021
Q1 | $10.1M | Hold |
3,275,616
| – | – | 1.62% | 10 |
|
|
2020
Q4 | $11.7M | Hold |
3,275,616
| – | – | 2.42% | 6 |
|
|
2020
Q3 | $13.1M | Hold |
3,275,616
| – | – | 3.46% | 6 |
|
|
2020
Q2 | $8.91M | Hold |
3,275,616
| – | – | 1.84% | 6 |
|
|
2020
Q1 | $6.91M | Hold |
3,275,616
| – | – | 1.72% | 5 |
|
|
2019
Q4 | $17.8M | Hold |
3,275,616
| – | – | 3.64% | 4 |
|
|
2019
Q3 | $9.86M | Hold |
3,275,616
| – | – | 1.97% | 6 |
|
|
2019
Q2 | $12.3M | Hold |
3,275,616
| – | – | 2.27% | 7 |
|
|
2019
Q1 | $13.2M | Hold |
3,275,616
| – | – | 2.55% | 6 |
|
|
2018
Q4 | $12M | Hold |
3,275,616
| – | – | 2.52% | 6 |
|
|
2018
Q3 | $28.1M | Hold |
3,275,616
| – | – | 4.42% | 5 |
|
|
2018
Q2 | $36M | Hold |
3,275,616
| – | – | 5.51% | 5 |
|
|
2018
Q1 | $34M | Buy |
3,275,616
+588,235
| +22% | +$5.56M | 6.48% | 4 |
|
|
2017
Q4 | $27.8M | Hold |
2,687,381
| – | – | 6.61% | 4 |
|
|
2017
Q3 | $42.8M | Hold |
2,687,381
| – | – | 10.94% | 3 |
|
|
2017
Q2 | $32.5M | Hold |
2,687,381
| – | – | 7.63% | 3 |
|
|
2017
Q1 | $55.8M | Hold |
2,687,381
| – | – | 13.73% | 3 |
|
|
2016
Q4 | $38.4M | Hold |
2,687,381
| – | – | 10.58% | 3 |
|
|
2016
Q3 | $44.2M | Hold |
2,687,381
| – | – | 8.33% | 4 |
|
|
2016
Q2 | $28.7M | Hold |
2,687,381
| – | – | 4.7% | 4 |
|
|
2016
Q1 | $29.2M | Buy |
+2,687,381
| New | +$38.6M | 5.33% | 5 |
|
Other funds holding CRVS
O
VC
PA
DTC
B
Adams Street Partners's CRVS Position: Q2 2026 in Review
Adams Street Partners held its Corvus Pharmaceuticals (CRVS) position steady in Q2 2026 at 3,275,616 shares worth $48.9M. The position accounts for 11.06% of the portfolio, ranked #4.
Adams Street Partners first reported a position in CRVS in Q1 2016 and has held it in 42 quarters since. The position peaked at $55.8M in Q1 2017. 173 funds tracked by Wall St. Rank hold CRVS as of Q2 2026.
- Adams Street Partners held 3,275,616 shares of Corvus Pharmaceuticals worth $48.9M as of Q2 2026.
- Adams Street Partners left its Corvus Pharmaceuticals share count unchanged in Q2 2026.
- Corvus Pharmaceuticals made up 11.06% of Adams Street Partners's portfolio in Q2 2026, its #4 holding.
- Adams Street Partners first reported a position in Corvus Pharmaceuticals in Q1 2016 and has held it in 42 quarters since.
- Adams Street Partners's Corvus Pharmaceuticals position peaked at $55.8M in Q1 2017.
- 173 funds tracked by Wall St. Rank held Corvus Pharmaceuticals as of Q2 2026.
Based on Adams Street Partners's 13F filing for Q2 2026, filed 14 Aug 2026.